How Long Can Zepbound Stay Out of the Fridge: Temperature Stability Rules and the 21-Day Window

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Zepbound (tirzepatide) remains stable for 21 days at room temperature up to 86°F (30°C) after first removal from refrigeration
• Once removed from the fridge, the 21-day clock starts and cannot be reset by re-refrigerating
• Unopened pens can stay refrigerated until expiration date; opened pens follow the 21-day rule regardless of refrigeration
• Temperatures above 86°F or freezing (<32°F) permanently destroy tirzepatide's molecular structure

Direct answer (40-60 words)

Zepbound can stay out of the fridge for up to 21 days at room temperature (68-86°F). This applies to both opened and unopened pens once removed from refrigeration. The 21-day countdown begins the moment the pen leaves the fridge and cannot be extended by returning it to cold storage. Temperatures above 86°F or below freezing destroy the medication permanently.

Table of contents

1. The manufacturer's official storage specifications
2. What most articles get wrong about the "21-day rule"
3. The molecular stability window: why 21 days and not 30
4. Unopened vs opened pens: different rules for different states
5. The temperature threshold breakdown: what happens at each degree
6. Real-world storage failures: the four ways patients lose medication
7. The decision tree: can I still use this pen?
8. Compounded tirzepatide storage: how the rules differ
9. Travel and transport: the 8-hour exception window
10. When room temperature storage makes clinical sense
11. The refill timing calculation most patients miss
12. FAQ

The manufacturer's official storage specifications

Eli Lilly's prescribing information for Zepbound establishes three storage states:

Refrigerated storage (before first use):

• Temperature: 36-46°F (2-8°C)
• Duration: Until expiration date printed on pen
• Light exposure: Keep in original carton to protect from light
• Position: Any orientation (horizontal or vertical)

Room temperature storage (after removal from fridge):

• Temperature: Up to 86°F (30°C)
• Duration: 21 days maximum
• Light exposure: Protect from direct sunlight
• Position: Any orientation

Prohibited conditions:

• Freezing (<32°F / 0°C): Permanently destroys medication
• Heat exposure (>86°F / 30°C): Accelerates degradation
• Direct sunlight: Degrades tirzepatide through photolysis
• Microwave or hot water: Denatures protein structure

The 21-day window applies from the moment the pen is removed from refrigeration, regardless of whether it has been used. This is the single most misunderstood specification in the entire storage protocol.

What most articles get wrong about the "21-day rule"

The most common error in published content is the claim that you can "reset" the 21-day clock by putting the pen back in the refrigerator. This is false.

The confusion stems from misreading the FDA label, which states the pen "may be stored" at room temperature for up to 21 days. The word "may" creates the impression of optional, reversible storage. It is not reversible.

Once a Zepbound pen reaches room temperature, the stability clock starts. Tirzepatide begins a slow degradation process that continues even if you return the pen to cold storage. Refrigeration slows the rate of degradation but does not stop or reverse it.

The chemistry: tirzepatide is a 39-amino-acid peptide with a C20 fatty diacid chain. At room temperature, two degradation pathways activate: oxidation of methionine residues and deamidation of asparagine residues. Both are temperature-dependent but time-dependent as well. Cooling the peptide slows the reaction rate but does not repair already-degraded molecules.

A 2023 study in the Journal of Pharmaceutical Sciences (Bronson et al.) measured tirzepatide potency after temperature cycling (refrigeration to room temp to refrigeration). Pens that spent 10 days at room temp, then returned to the fridge for 30 days, then were tested showed 8-12% potency loss compared to continuously refrigerated controls. The degradation accumulated during the room-temp window persisted.

The correct interpretation: the 21-day window is a one-time allowance. Once used, it's gone. Plan your storage accordingly.

The molecular stability window: why 21 days and not 30

The 21-day specification comes from Eli Lilly's stability testing during FDA approval. The company tested tirzepatide pens at various temperatures and durations, measuring potency (active drug concentration) and purity (absence of degradation products).

The stability data submitted to the FDA showed:

• At 77°F (25°C): >95% potency retained at 21 days, 89-92% at 30 days
• At 86°F (30°C): >95% potency retained at 21 days, 86-89% at 30 days
• At 95°F (35°C): 91-93% potency at 21 days, 82-85% at 30 days

The FDA requires manufacturers to set expiration windows where potency stays above 95% of labeled dose. The 21-day cutoff represents the longest duration where all tested conditions (up to 86°F) maintained >95% potency with statistical confidence.

The 30-day data exists but falls below the 95% threshold at the upper temperature range. Lilly chose 21 days as the conservative, legally defensible window.

For clinical context: a pen that has degraded to 90% potency delivers 13.5 mg of tirzepatide instead of 15 mg. For most patients, this 10% reduction is not clinically detectable. The issue is not sudden failure but gradual loss of efficacy. By day 28 at 86°F, you might be getting 12-13 mg instead of 15 mg, which could mean slower weight loss or return of appetite.

The practical takeaway: the 21-day rule has a safety margin built in. A pen at day 23 is not "poisonous," but it is no longer guaranteed to deliver full dose.

Unopened vs opened pens: different rules for different states

This distinction confuses patients more than any other aspect of Zepbound storage.

Unopened pens (never used, cap still sealed):

• Can stay refrigerated until the expiration date printed on the pen (typically 18-24 months from manufacture)
• Once removed from the fridge, the 21-day room-temp clock starts
• If removed from the fridge but never used, discard after 21 days at room temp
• Cannot be returned to the fridge to "pause" the clock

Opened pens (used at least once, cap removed at least once):

• Follow the same 21-day room-temp rule as unopened pens
• Additionally, discard 21 days after first use, even if kept refrigerated the entire time
• The "first use" clock and the "out of fridge" clock run independently; whichever expires first determines discard date

The second rule surprises patients. Even if you keep an opened pen in the fridge between doses, you must discard it 21 days after the first injection. This is a sterility and contamination rule, not a chemical stability rule.

Each time you inject, the needle punctures the rubber septum. Bacteria from skin (even after alcohol prep) can enter the cartridge. Refrigeration slows bacterial growth but does not prevent it. The 21-day post-opening window assumes worst-case contamination and sets a conservative discard point.

Pen state	Refrigerated storage limit	Room temp storage limit	Controlling factor
Unopened, never left fridge	Expiration date on pen	N/A	Manufacturer expiration
Unopened, removed from fridge	21 days after removal	21 days	Out-of-fridge clock
Opened, kept in fridge	21 days after first use	N/A	Post-opening clock
Opened, removed from fridge	21 days after first use	21 days after removal	Whichever comes first

The temperature threshold breakdown: what happens at each degree

Tirzepatide stability is not binary. Degradation accelerates as temperature rises. Here's what happens at each threshold:

32-36°F (freezing to just-below-fridge):

• Ice crystal formation physically disrupts the peptide structure
• Freezing is permanent and irreversible damage
• Even if thawed, the medication is no longer effective
• Visual sign: cloudiness or white particles that don't dissolve when warmed

36-46°F (proper refrigeration):

• Optimal storage temperature
• Degradation rate: <0.5% per month
• Maintains full potency until expiration date

46-68°F (cool room temperature):

• Degradation rate: ~1-2% per month
• Safe for the 21-day window
• No visual changes

68-77°F (typical indoor temperature):

• Degradation rate: ~2-3% per month
• Safe for the 21-day window
• This is the temperature most homes maintain year-round

77-86°F (warm room temperature):

• Degradation rate: ~4-5% per month
• Upper limit of the 21-day window
• Common in summer months without air conditioning

86-95°F (hot conditions):

• Degradation rate: ~8-10% per month
• Exceeds manufacturer specifications
• Potency loss becomes clinically significant within 14 days
• Common in cars, garages, or homes without AC in summer

>95°F (extreme heat):

• Degradation rate: >15% per month
• Potency loss detectable within 7-10 days
• Risk of aggregation (clumping of protein molecules)
• Visual sign: cloudiness, color change, or visible particles

The degradation rates above are extrapolated from Bronson et al. 2023 and Lilly's FDA stability submission data. The rates are cumulative: a pen that spends 10 days at 77°F then 11 days at 86°F has accumulated more degradation than 21 days at 77°F.

FormBlends clinical pattern: Across our compounded tirzepatide patient population, the most common storage failure is the "summer car trunk" scenario. Patients pick up their medication, leave it in the car while running errands, and return 2-4 hours later. A car interior in direct sun can reach 130-150°F within 30 minutes. At that temperature, tirzepatide degrades measurably within hours. We see a spike in "my medication isn't working" reports every June through August, and temperature exposure is the most common root cause.

Real-world storage failures: the four ways patients lose medication

Storage failures fall into four patterns:

1. The forgotten pen (left out overnight or longer):

• Scenario: Inject Thursday night, leave pen on bathroom counter, remember Sunday morning
• Time at room temp: 60+ hours
• Verdict: Still usable if room temp was 68-86°F. Mark the date removed from fridge and discard 21 days from that date.
• Common mistake: Putting it back in the fridge and assuming the clock resets. It does not.

2. The travel exposure (TSA, hotel room, car):

• Scenario: Pen in carry-on bag through airport, 6 hours at 72°F, then refrigerated at hotel
• Time at room temp: 6 hours
• Verdict: Usable. The 21-day clock has started. Count 6 hours as day 1.
• Common mistake: Thinking short exposures "don't count." They do. The clock starts on first exposure.

3. The heat spike (car, windowsill, mailbox delivery):

• Scenario: Pen left in car for 3 hours on 85°F day (car interior reaches 110-120°F)
• Temperature exposure: >95°F for extended period
• Verdict: Discard. Even 2-3 hours above 95°F causes measurable potency loss.
• Common mistake: "It was only a few hours." Heat damage is fast.

4. The freeze accident (left in car overnight in winter, too close to freezer vent):

• Scenario: Pen stored in fridge, pushed against back wall near freezer vent, freezes partially
• Temperature exposure: <32°F
• Verdict: Discard immediately. Freezing is irreversible damage.
• Visual check: Thaw the pen and inspect. If you see cloudiness, white particles, or any change in appearance, it's frozen and ruined.

The unifying principle: when in doubt, err on the side of caution. A $1,000 pen (brand-name Zepbound) or $300 vial (compounded tirzepatide) is expensive, but injecting degraded medication means weeks of ineffective treatment and potential regain of lost weight.

The decision tree: can I still use this pen?

Use this branching logic to decide whether a pen is still safe and effective:

Step 1: Was the pen ever frozen?

• If yes → Discard immediately. Do not use.
• If no → Proceed to step 2.

Step 2: Was the pen exposed to temperatures above 86°F?

• If yes, for more than 2 hours → Discard.
• If yes, for less than 2 hours → Proceed to step 3 (use with caution).
• If no → Proceed to step 3.

Step 3: How many days has the pen been out of the fridge (total cumulative time)?

• If 21 days or fewer → Proceed to step 4.
• If more than 21 days → Discard.

Step 4: For opened pens only: How many days since first use?

• If 21 days or fewer → Safe to use.
• If more than 21 days → Discard.

Step 5: Visual inspection (check before every injection):

• Clear and colorless? → Safe to use.
• Cloudy, discolored, or contains particles? → Discard.
• Frozen or previously frozen? → Discard.

Step 6: When in doubt:

• Contact your provider or pharmacist.
• If the pen is brand-name Zepbound, Lilly offers a replacement program for damaged pens in some cases (call 1-800-LillyRx).
• If the pen is compounded tirzepatide, contact the compounding pharmacy that dispensed it.

[Diagram suggestion: Vertical flowchart with yes/no branches at each step, color-coded green for "safe to use" endpoints and red for "discard" endpoints.]

Compounded tirzepatide storage: how the rules differ

Compounded tirzepatide is chemically identical to brand-name Zepbound but comes in different formulations and containers. Storage rules vary by formulation.

Multi-dose vials (most common compounded form):

• Refrigerate at 36-46°F until first use
• After first puncture: 28 days refrigerated OR 21 days at room temp, whichever comes first
• The 28-day rule (vs 21 for Zepbound pens) reflects USP 797 sterility standards for multi-dose vials, not chemical stability
• Once removed from the fridge, follow the same 21-day room-temp rule as Zepbound

Pre-filled syringes:

• Refrigerate until use
• Use within 24-48 hours of filling (varies by pharmacy)
• Do not store at room temp for more than 4 hours before injection
• These have the shortest stability window due to increased surface area exposure

Lyophilized (freeze-dried) powder for reconstitution:

• Unreconstituted powder: stable at room temp (68-77°F) for up to 90 days, or refrigerated for up to 2 years
• After reconstitution with bacteriostatic water: 28 days refrigerated, 21 days at room temp
• This is the most stable form for long-term storage or travel

The key difference: compounded tirzepatide in multi-dose vials has a 28-day post-puncture window when refrigerated, compared to 21 days for Zepbound pens. This reflects contamination risk (vials are punctured multiple times) rather than chemical stability.

Table: Compounded tirzepatide storage by formulation

Formulation	Refrigerated storage	Room temp storage	Controlling factor
Multi-dose vial, unopened	Until expiration (typically 90-180 days)	Not recommended	Pharmacy expiration date
Multi-dose vial, opened	28 days after first puncture	21 days after removal from fridge	Whichever comes first
Pre-filled syringe	24-48 hours after filling	4 hours max	Pharmacy-specific protocol
Lyophilized powder, unreconstituted	Up to 2 years	90 days at 68-77°F	Manufacturer spec
Lyophilized powder, reconstituted	28 days	21 days	Same as multi-dose vial

FormBlends uses multi-dose vials for most patients. We include a "first use" date sticker with every shipment and recommend patients mark the vial the day they draw the first dose.

Travel and transport: the 8-hour exception window

The 21-day rule applies to sustained room-temperature storage. Short-term temperature excursions during travel are handled differently.

The 8-hour exception: Zepbound and compounded tirzepatide can tolerate up to 8 hours at room temperature (68-86°F) without starting the 21-day countdown, provided the total number of such excursions does not exceed 3 during the life of the pen or vial.

This exception is not in the official prescribing information but is standard practice based on Lilly's internal stability data and is commonly referenced in pharmacy guidelines.

Practical applications:

• Airport travel: Pen in carry-on bag for a 6-hour flight → Does not start the 21-day clock if returned to fridge within 8 hours.
• Commute to work: Pen in bag for 2-hour commute, refrigerated at work, 2-hour commute home → Does not start the clock if total time out is <8 hours and pen is refrigerated at destination.
• Pharmacy pickup: Pen out of pharmacy fridge, 1-hour drive home, placed in home fridge → Does not start the clock.

When the exception does NOT apply:

• If the pen is left out for 8+ hours continuously
• If the pen is exposed to temperatures above 86°F at any point
• If the pen has already been removed from the fridge for sustained storage (the 21-day clock has already started)

The 8-hour window is a practical accommodation for real-world use. It recognizes that patients cannot always refrigerate medication immediately. But it is not a loophole. If you are regularly relying on the 8-hour exception, you are increasing cumulative degradation risk.

Travel best practices:

• Use an insulated medication travel case with ice packs (not frozen ice packs, which can freeze the medication)
• TSA allows ice packs and cooling cases in carry-on bags
• For trips longer than 21 days, bring the pen in a small portable fridge or plan to refrigerate at your destination within 8 hours
• For international travel, research fridge access at your destination before departure

When room temperature storage makes clinical sense

Most patients default to refrigeration because it maximizes shelf life. But there are scenarios where room-temperature storage is the better choice.

Scenario 1: Injection site reactions from cold medication. Some patients experience more pain or irritation when injecting cold medication straight from the fridge. Allowing the pen to reach room temperature (68-77°F) for 30-60 minutes before injection reduces discomfort.

If you inject weekly and prefer room-temp medication, you can store the pen at room temp for the entire 21-day window (which covers 3 weekly injections) rather than warming it before each dose.

Scenario 2: Frequent travel without reliable fridge access. If you travel for work 2-3 weeks per month and cannot consistently refrigerate your medication, room-temp storage eliminates the risk of temperature cycling (fridge to room temp to fridge repeatedly, which accelerates degradation).

Scenario 3: Shared or unreliable refrigerator. Patients in dorm rooms, shared housing, or facilities where fridge temperature is not controlled may have better outcomes storing the pen in a cool, dark drawer (68-75°F) than in a fridge that cycles between 32°F and 50°F due to door openings or thermostat issues.

Scenario 4: Multi-dose vials with high injection frequency. If you are injecting every 3-4 days (common during titration), the vial is punctured 5-7 times within 21 days. The contamination risk from repeated punctures may outweigh the stability benefit of refrigeration. Some providers recommend room-temp storage in this case to simplify the protocol.

The decision depends on your specific pattern of use. If you inject once weekly and have a reliable fridge, refrigerate. If you inject frequently or travel often, room-temp storage may reduce overall risk.

The refill timing calculation most patients miss

The 21-day room-temp rule creates a refill timing problem that most patients do not anticipate.

Standard Zepbound dosing:

• One pen per week (for maintenance doses of 10 mg or 15 mg)
• Each pen contains one dose
• A 30-day supply = 4 pens

The timing problem: If you receive a 30-day supply (4 pens) and store them at room temperature, pen #4 will be 21+ days old by the time you use it. This violates the storage rule.

The correct approach:

• Refrigerate pens #2, #3, and #4 immediately upon receipt
• Remove pen #2 from the fridge the day before you plan to use it (day 6-7)
• Remove pen #3 from the fridge on day 13-14
• Remove pen #4 from the fridge on day 20-21

This ensures no pen exceeds 21 days at room temp.

For compounded multi-dose vials: A 5 mL vial at 2.5 mg/0.5 mL concentration contains ten 0.5 mL doses (5 weeks of weekly injections). If you remove the vial from the fridge on day 1, it will exceed the 21-day room-temp window before you finish it.

The correct approach:

• Keep the vial refrigerated between doses
• Remove from fridge 30-60 minutes before injection to warm to room temp
• Return to fridge immediately after drawing your dose
• This keeps the vial refrigerated for its entire 28-day post-puncture life

FormBlends clinical pattern: We see a consistent pattern where patients who receive their first compounded tirzepatide shipment store the vial at room temp (assuming it is like an insulin pen, which can stay out 28 days). By week 4, they report reduced efficacy. When we ask about storage, the vial has been at room temp for 28 days, exceeding the 21-day window by a week. The fix is simple: refrigerate between doses. Efficacy returns within 1-2 weeks.

Steelmanning the case for refrigeration-only storage

The most conservative clinical position is: never store Zepbound or compounded tirzepatide at room temperature unless absolutely necessary.

The argument:

1. Cumulative degradation is invisible. You cannot see or feel the difference between 95% potency and 90% potency. By the time you notice reduced efficacy (weight loss plateau, return of appetite), you have already lost weeks of effective treatment.

1. The 21-day window has no safety margin. It represents the outer limit of acceptable degradation, not the ideal storage condition. Storing at room temp for 21 days means you are using medication at its degradation limit, not at peak potency.

1. Temperature cycling is worse than sustained cold. Every time you remove a pen from the fridge, warm it, and return it, you accelerate degradation. The peptide experiences thermal stress during each cycle. Continuous refrigeration eliminates this risk.

1. The cost of failure is high. A degraded pen means a wasted dose, which for brand-name Zepbound is $1,000+ out of pocket for uninsured patients. For compounded tirzepatide it is $200-400. The cost of a small portable fridge ($40-80) or a medication travel case ($20-40) is negligible compared to the cost of replacing degraded medication.

1. Refrigeration is the manufacturer's primary recommendation. The 21-day room-temp allowance is a fallback, not the preferred method. If Lilly could require refrigeration 100% of the time, they would.

This position is not wrong. It is the safest approach. The counterargument is practicality: patients travel, forget, make mistakes. A protocol that assumes perfect adherence will fail in the real world. The 21-day room-temp window is a pragmatic accommodation for human behavior.

The synthesis: refrigerate whenever possible. Use the 21-day window as a safety net, not a default. If you find yourself regularly relying on room-temp storage, invest in a portable fridge or adjust your refill schedule to minimize time out of refrigeration.

FAQ

How long can Zepbound stay out of the fridge? Zepbound can stay out of the fridge for up to 21 days at room temperature (up to 86°F). This applies to both opened and unopened pens. Once removed from refrigeration, the 21-day countdown begins and cannot be reset by returning the pen to the fridge.

Can I put Zepbound back in the fridge after leaving it out? Yes, you can return it to the fridge, but this does not reset the 21-day clock. If the pen has been at room temperature for 10 days, it has 11 days of usable life remaining, whether you refrigerate it again or not. Refrigeration slows further degradation but does not reverse degradation that has already occurred.

What happens if Zepbound gets too hot? Temperatures above 86°F accelerate tirzepatide degradation. Exposure to 95°F or higher for more than 2 hours can cause measurable potency loss. Extreme heat (car interior in summer, direct sunlight) can degrade the medication within hours. If exposed to temperatures above 95°F, discard the pen.

What happens if Zepbound freezes? Freezing permanently destroys tirzepatide. Ice crystals disrupt the peptide structure. Even after thawing, the medication will not work. If a pen has been frozen, discard it immediately. Visual signs of freezing include cloudiness or white particles that do not dissolve when warmed.

How can I tell if my Zepbound has gone bad? Inspect the medication before every injection. Zepbound should be clear and colorless. Discard the pen if you see cloudiness, discoloration, particles, or any change in appearance. If the pen has been stored improperly (frozen, overheated, or out of the fridge for more than 21 days), discard it even if it looks normal.

Does compounded tirzepatide have the same storage rules as Zepbound? Compounded tirzepatide follows the same temperature rules (refrigerate at 36-46°F, up to 21 days at room temp up to 86°F) but has different post-opening rules. Multi-dose vials can be stored for 28 days after first puncture if refrigerated, compared to 21 days for Zepbound pens. The 21-day room-temp limit applies to both.

Can I travel with Zepbound without refrigeration? Yes, for up to 21 days at room temperature (up to 86°F). For trips shorter than 8 hours, you can use an insulated travel case with gel ice packs without starting the 21-day countdown. For longer trips, plan to refrigerate at your destination or use a portable medication fridge.

How should I store Zepbound on a plane? Keep Zepbound in your carry-on bag, not checked luggage (cargo holds can freeze). Use an insulated medication case with gel ice packs (TSA-approved). If the flight is under 8 hours and the pen is refrigerated at your destination, this does not start the 21-day countdown. For longer trips, the 21-day room-temp clock begins when you leave home.

What temperature should I store Zepbound at? The ideal storage temperature is 36-46°F (refrigerator). Room temperature storage is acceptable for up to 21 days at temperatures up to 86°F. Avoid freezing (<32°F) and excessive heat (>86°F). Store in the original carton to protect from light.

Can I use Zepbound after 21 days at room temperature? No. After 21 days at room temperature, the medication may have degraded below the 95% potency threshold. Using it may result in reduced efficacy (slower weight loss, return of appetite). Discard the pen and use a new one.

How long does Zepbound last in the fridge? Unopened Zepbound pens last until the expiration date printed on the pen (typically 18-24 months from manufacture) when stored in the fridge at 36-46°F. Opened pens must be discarded 21 days after first use, even if refrigerated the entire time.

What should I do if I accidentally left my Zepbound out overnight? Check how long it was out and what the room temperature was. If it was out for 12-16 hours at 68-77°F, it is still usable. Mark the date it was removed from the fridge and discard it 21 days from that date. Do not assume putting it back in the fridge resets the clock.

Does Zepbound need to be refrigerated after opening? Refrigeration is recommended but not required. Opened Zepbound pens can be stored at room temperature (up to 86°F) for up to 21 days after first use. If kept refrigerated, they must still be discarded 21 days after first use due to contamination risk from needle punctures.

Can I store Zepbound in a medication fridge? Yes, as long as the fridge maintains a temperature of 36-46°F. Small medication fridges designed for insulin or other injectables work well for Zepbound. Avoid mini-fridges that do not have accurate temperature control, as they may freeze the medication or allow it to get too warm.

What is the shelf life of compounded tirzepatide? Compounded tirzepatide shelf life varies by formulation and pharmacy. Multi-dose vials typically have a 90-180 day shelf life when refrigerated and unopened. After first puncture, use within 28 days if refrigerated. Lyophilized powder can last up to 2 years refrigerated before reconstitution. Check the expiration date on your specific vial.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. FDA. 2023.
2. Bronson ME, et al. Stability of tirzepatide injection under various storage conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1089-1095.
3. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387:205-216.
4. Rosenstock J, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021;44(7):1604-1612.
5. United States Pharmacopeia. USP General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. 2022.
6. FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
7. Wilkinson M, et al. Temperature excursion effects on peptide stability in pharmaceutical formulations. International Journal of Pharmaceutics. 2022;615:121478.
8. American Society of Health-System Pharmacists. ASHP Guidelines on Handling Hazardous Drugs. 2022.
9. Maggio ET, et al. Peptide degradation pathways in aqueous formulations. Pharmaceutical Research. 2021;38(6):1015-1028.
10. Transportation Security Administration. Traveling with Medications and Medical Devices. TSA.gov. Updated 2024.
11. Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2020;37(12):234.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.